| Insideraktier | 46.139.601 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Entasis Therapeutics Holdings Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ETTX / Entasis Therapeutics Holdings Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ETTX / Entasis Therapeutics Holdings Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-13 | 2022-07-11 | 4 | Innoviva, Inc. | ETTX | Common Stock | I | 2,2000 | 7.598.814 | 16.717 | 29.270.476 | ||||
| 2022-07-13 | 2022-07-08 | 4 | Innoviva, Inc. | ETTX | Common Stock | I | 2,2000 | 11.671.662 | 25.678 | 21.671.662 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Wagner Kristie Ann | ETTX | Common Stock | D | -80.500 | 0 | ||||||
| 2022-07-11 | 2022-07-11 | 4 | Ronsheim Matthew | ETTX | Common Stock | D | -150.000 | 0 | ||||||
| 2022-07-11 | 2022-07-07 | 4 | Ronsheim Matthew | ETTX | Common Stock | D | 2,2000 | -17.572 | -39 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Triola Anna Diaz | ETTX | Common Stock | D | -125.000 | 0 | ||||||
| 2022-07-11 | 2022-07-11 | 4 | Tommasi Rubin | ETTX | Common Stock | D | -150.000 | 0 | ||||||
| 2022-07-11 | 2022-07-07 | 4 | Tommasi Rubin | ETTX | Common Stock | D | 2,2000 | -39.596 | -87 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Perros Manoussos | ETTX | Common Stock | D | -478.500 | 0 | ||||||
| 2022-07-11 | 2022-07-07 | 4 | Perros Manoussos | ETTX | Common Stock | D | 2,2000 | -56.072 | -123 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Mueller John Patrick | ETTX | Common Stock | D | -150.000 | 0 | ||||||
| 2022-07-11 | 2022-07-07 | 4 | Mueller John Patrick | ETTX | Common Stock | D | 2,2000 | -17.092 | -38 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Mayer Howard | ETTX | Common Stock | D | 2,2000 | -27.500 | -61 | 0 | ||||
| 2022-07-11 | 2022-07-07 | 4 | Mayer Howard | ETTX | Common Stock | D | 2,2000 | -22.000 | -48 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Meek David D. | ETTX | Common Stock | D | 2,2000 | -27.500 | -61 | 0 | ||||
| 2022-07-11 | 2022-07-07 | 4 | Meek David D. | ETTX | Common Stock | D | 2,2000 | -22.000 | -48 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | HASTINGS DAVID C | ETTX | Common Stock | D | 2,2000 | -27.500 | -61 | 0 | ||||
| 2022-07-11 | 2022-07-07 | 4 | HASTINGS DAVID C | ETTX | Common Stock | D | 2,2000 | -22.000 | -48 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Keiley Elizabeth M | ETTX | Common Stock | D | -150.000 | 0 | ||||||
| 2022-07-11 | 2022-07-07 | 4 | Keiley Elizabeth M | ETTX | Common Stock | D | 2,2000 | -17.572 | -39 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Behanna Heather | ETTX | Common Stock | D | 2,2000 | -27.500 | -61 | 0 | ||||
| 2022-07-11 | 2022-07-07 | 4 | Behanna Heather | ETTX | Common Stock | D | 2,2000 | -22.000 | -48 | 0 | ||||
| 2022-07-11 | 2022-07-11 | 4 | Altarac David | ETTX | Common Stock | D | -150.000 | 0 | ||||||
| 2022-07-11 | 2022-07-07 | 4 | Altarac David | ETTX | Common Stock | D | 2,2000 | -17.572 | -39 | 0 | ||||
| 2022-02-25 | 3 | Wagner Kristie Ann | ETTX | Common Stock | D | 70.500 | ||||||||
| 2022-02-25 | 2022-02-24 | 4 | Wagner Kristie Ann | ETTX | Common Stock | D | 10.000 | 80.500 | ||||||
| 2022-02-23 | 2022-02-18 | 4 | Innoviva, Inc. | ETTX | Convertible Promissory Note | I | 1,48 | 0 | 10.000.000 | |||||
| 2022-02-23 | 2022-02-18 | 4 | Innoviva, Inc. See footnotes | ETTX | Warrants to Purchase Common Stock | I | 1,48 | 0 | 10.000.000 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Behanna Heather | ETTX | Stock Option (Right to Buy) | D | 2,44 | 5.769 | 5.769 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Behanna Heather | ETTX | Stock Option (Right to Buy) | D | 6,12 | -7.500 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Behanna Heather | ETTX | Stock Option (Right to Buy) | D | 2,44 | 11.538 | 11.538 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Behanna Heather | ETTX | Stock Option (Right to Buy) | D | 5,66 | -15.000 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Keiley Elizabeth M | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 20.833 | 20.833 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Keiley Elizabeth M | ETTX | Employee Stock Option (Right to Buy) | D | 6,90 | -25.000 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | HASTINGS DAVID C | ETTX | Stock Option (Right to Buy) | D | 2,44 | 5.769 | 5.769 | |||||
| 2022-02-15 | 2021-07-16 | 4 | HASTINGS DAVID C | ETTX | Stock Option (Right to Buy) | D | 6,12 | -7.500 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | HASTINGS DAVID C | ETTX | Stock Option (Right to Buy) | D | 2,44 | 11.538 | 11.538 | |||||
| 2022-02-15 | 2021-07-16 | 4 | HASTINGS DAVID C | ETTX | Stock Option (Right to Buy) | D | 5,66 | -15.000 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | HASTINGS DAVID C | ETTX | Stock Option (Right to Buy) | D | 2,44 | 9.276 | 9.276 | |||||
| 2022-02-15 | 2021-07-16 | 4 | HASTINGS DAVID C | ETTX | Stock Option (Right to Buy) | D | 6,85 | -12.060 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Altarac David | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 92 | 92.307 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Altarac David | ETTX | Employee Stock Option (Right to Buy) | D | 5,70 | -120.000 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Meek David D. | ETTX | Stock Option (Right to Buy) | D | 2,44 | 5.769 | 5.769 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Meek David D. | ETTX | Stock Option (Right to Buy) | D | 6,12 | -7.500 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Meek David D. | ETTX | Stock Option (Right to Buy) | D | 2,44 | 11.538 | 11.538 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Meek David D. | ETTX | Stock Option (Right to Buy) | D | 6,12 | -15.000 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 95.000 | 95.000 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 5,66 | -123.500 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 44.276 | 44.276 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | -79.698 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 128.531 | 128.531 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 6,85 | -166.623 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 58.307 | 58.307 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 4,98 | -87.462 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 43.460 | 43.460 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 5,66 | -56.500 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 4.035 | 4.035 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | -7.265 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 12.993 | 12.993 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 6,85 | -16.892 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 15.210 | 15.210 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 4,98 | -22.816 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mayer Howard | ETTX | Stock Option (Right to Buy) | D | 2,44 | 12.500 | 12.500 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Mayer Howard | ETTX | Stock Option (Right to Buy) | D | 6,44 | -15.000 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Ronsheim Matthew | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 33.333 | 33.333 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Ronsheim Matthew | ETTX | Employee Stock Option (Right to Buy) | D | 5,12 | -40.000 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Gutch Michael | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 43.460 | 43.460 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Gutch Michael | ETTX | Employee Stock Option (Right to Buy) | D | 5,66 | -56.500 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Gutch Michael | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 8.863 | 8.863 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Gutch Michael | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | -15.956 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Gutch Michael | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 23.081 | 23.081 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Gutch Michael | ETTX | Employee Stock Option (Right to Buy) | D | 6,85 | -30.006 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 43.460 | 43.460 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 5,66 | -56.500 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 28.006 | 28.006 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | -50.411 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 12.024 | 12.024 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 6,85 | -15.632 | 0 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 2,44 | 15.210 | 15.210 | |||||
| 2022-02-15 | 2021-07-16 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 4,98 | -22.816 | 0 | |||||
| 2022-01-19 | 2022-01-18 | 4 | Tommasi Rubin | ETTX | Common Stock | D | 125.000 | 189.596 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Gutch Michael | ETTX | Common Stock | D | 125.000 | 167.572 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Mueller John Patrick | ETTX | Common Stock | D | 125.000 | 167.092 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Perros Manoussos | ETTX | Common Stock | D | 125.000 | 534.572 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Ronsheim Matthew | ETTX | Common Stock | D | 125.000 | 167.572 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Keiley Elizabeth M | ETTX | Common Stock | D | 125.000 | 167.572 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Behanna Heather | ETTX | Common Stock | D | 27.500 | 49.500 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Mayer Howard | ETTX | Common Stock | D | 27.500 | 49.500 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | HASTINGS DAVID C | ETTX | Common Stock | D | 27.500 | 49.500 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Meek David D. | ETTX | Common Stock | D | 27.500 | 49.500 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Triola Anna Diaz | ETTX | Common Stock | D | 125.000 | 125.000 | ||||||
| 2022-01-19 | 2022-01-18 | 4 | Altarac David | ETTX | Common Stock | D | 125.000 | 167.572 | ||||||
| 2021-11-03 | 2021-11-02 | 4 | Ronsheim Matthew | ETTX | Common Stock | D | 2,9400 | -3.669 | -11 | 42.572 | ||||
| 2021-11-03 | 2021-11-02 | 4 | Altarac David | ETTX | Common Stock | D | 2,9400 | -3.669 | -11 | 42.572 | ||||
| 2021-11-03 | 2021-11-02 | 4 | Keiley Elizabeth M | ETTX | Common Stock | D | 2,9400 | -3.669 | -11 | 42.572 | ||||
| 2021-11-03 | 2021-11-02 | 4 | Perros Manoussos | ETTX | Common Stock | D | 2,9400 | -11.704 | -34 | 135.822 | ||||
| 2021-11-03 | 2021-11-02 | 4 | Mueller John Patrick | ETTX | Common Stock | D | 2,9400 | -3.907 | -11 | 42.092 | ||||
| 2021-11-03 | 2021-11-02 | 4 | Tommasi Rubin | ETTX | Common Stock | D | 2,9400 | -3.669 | -11 | 64.596 | ||||
| 2021-11-03 | 2021-11-02 | 4 | Gutch Michael | ETTX | Common Stock | D | 2,9400 | -3.669 | -11 | 42.572 | ||||
| 2021-10-20 | 2021-10-19 | 4 | Perros Manoussos | ETTX | Common Stock | D | 3,1900 | -11.974 | -38 | 147.526 | ||||
| 2021-10-20 | 2021-10-19 | 4 | Perros Manoussos | ETTX | Common Stock | D | 79.750 | 159.500 | ||||||
| 2021-10-20 | 2021-10-19 | 4 | Mueller John Patrick | ETTX | Common Stock | D | 3,1900 | -4.001 | -13 | 45.999 | ||||
| 2021-10-20 | 2021-10-19 | 4 | Mueller John Patrick | ETTX | Common Stock | D | 25.000 | 50.000 | ||||||
| 2021-10-20 | 2021-10-19 | 4 | Tommasi Rubin | [ETTX] | Common Stock | D | 3,1900 | -3.759 | -12 | 68.265 | ||||
| 2021-10-20 | 2021-10-19 | 4 | Tommasi Rubin | [ETTX] | Common Stock | D | 25.000 | 72.024 | ||||||
| 2021-10-20 | 2021-10-19 | 4 | Gutch Michael | ETTX | Common Stock | D | 3,1900 | -3.759 | -12 | 46.241 | ||||
| 2021-10-20 | 2021-10-19 | 4 | Gutch Michael | ETTX | Common Stock | D | 25.000 | 50.000 | ||||||
| 2021-10-20 | 2021-10-19 | 4 | Keiley Elizabeth M | ETTX | Common Stock | D | 3,1900 | -3.759 | -12 | 46.241 | ||||
| 2021-10-20 | 2021-10-19 | 4 | Keiley Elizabeth M | ETTX | Common Stock | D | 25.000 | 50.000 | ||||||
| 2021-10-20 | 2021-10-19 | 4 | Altarac David | ETTX | Common Stock | D | 3,1900 | -3.759 | -12 | 46.241 | ||||
| 2021-10-20 | 2021-10-19 | 4 | Altarac David | ETTX | Common Stock | D | 25.000 | 50.000 | ||||||
| 2021-10-20 | 2021-10-19 | 4 | Ronsheim Matthew | ETTX | Common Stock | D | 3,1900 | -3.759 | -12 | 46.241 | ||||
| 2021-10-20 | 2021-10-19 | 4 | Ronsheim Matthew | ETTX | Common Stock | D | 25.000 | 50.000 | ||||||
| 2021-07-20 | 2021-07-19 | 4 | Triola Anna Diaz | ETTX | Stock Option (Right to Buy) | D | 2,49 | 100.000 | 100.000 | |||||
| 2021-06-11 | 2021-06-11 | 4 | Innoviva, Inc. | ETTX | Warrants to Purchase Common Stock | I | 2,00 | 2,0000 | 6.268.975 | 12.538 | 10.000.000 | |||
| 2021-06-11 | 2021-06-11 | 4 | Innoviva, Inc. | ETTX | Common Stock | I | 2,0000 | 6.268.975 | 12.538 | 10.000.000 | ||||
| 2021-05-20 | 2021-05-03 | 4 | Innoviva, Inc. | ETTX | Warrants to Purchase Common Stock | I | 2,00 | 2,0000 | 3.731.025 | 7.462 | 3.731.025 | |||
| 2021-05-20 | 2021-05-03 | 4 | Innoviva, Inc. | ETTX | Common Stock | I | 2,0000 | 3.731.025 | 7.462 | 3.731.025 | ||||
| 2021-04-02 | 2021-04-01 | 4 | Mayer Howard | ETTX | Common Stock | D | 22.000 | 22.000 | ||||||
| 2021-04-02 | 2021-04-01 | 4 | Behanna Heather | ETTX | Common Stock | D | 22.000 | 22.000 | ||||||
| 2021-04-02 | 2021-04-01 | 4 | Meek David D. | ETTX | Common Stock | D | 22.000 | 22.000 | ||||||
| 2021-04-02 | 2021-04-01 | 4 | HASTINGS DAVID C | ETTX | Common Stock | D | 22.000 | 22.000 | ||||||
| 2021-01-19 | 2021-01-15 | 4 | Tommasi Rubin | ETTX | Common Stock | D | 25.000 | 47.024 | ||||||
| 2021-01-19 | 2021-01-15 | 4 | Ronsheim Matthew | ETTX | Common Stock | D | 25.000 | 25.000 | ||||||
| 2021-01-19 | 2021-01-15 | 4 | Gutch Michael | ETTX | Common Stock | D | 25.000 | 25.000 | ||||||
| 2021-01-19 | 2021-01-15 | 4 | Keiley Elizabeth M | ETTX | Common Stock | D | 25.000 | 25.000 | ||||||
| 2021-01-19 | 2021-01-15 | 4 | Perros Manoussos | ETTX | Common Stock | D | 79.750 | 79.750 | ||||||
| 2021-01-19 | 2021-01-15 | 4 | Mueller John Patrick | ETTX | Common Stock | D | 25.000 | 25.000 | ||||||
| 2021-01-19 | 2021-01-15 | 4 | Altarac David | ETTX | Common Stock | D | 25.000 | 25.000 | ||||||
| 2020-10-06 | 2020-06-10 | 4 | HASTINGS DAVID C | ETTX | Stock Option (Right to Buy) | D | 2,98 | 11.000 | 11.000 | |||||
| 2020-10-06 | 2020-06-10 | 4 | Meek David D. | ETTX | Stock Option (Right to Buy) | D | 2,98 | 11.000 | 11.000 | |||||
| 2020-10-06 | 2020-06-10 | 4 | Mayer Howard | ETTX | Stock Option (Right to Buy) | D | 2,98 | 11.000 | 11.000 | |||||
| 2020-10-06 | 2020-06-10 | 4 | Behanna Heather | ETTX | Stock Option (Right to Buy) | D | 2,98 | 11.000 | 11.000 | |||||
| 2020-09-01 | 2020-09-01 | 4 | Innoviva, Inc. | ETTX | Warrants to Purchase Common Stock | D | 2,68 | 2,6750 | 4.672.897 | 12.500 | 18.672.897 | |||
| 2020-09-01 | 2020-09-01 | 4 | Innoviva, Inc. | ETTX | Common Stock | D | 2,6750 | 4.672.897 | 12.500 | 18.672.897 | ||||
| 2020-06-12 | 2020-06-11 | 4 | Innoviva, Inc. | ETTX | Warrants to Purchase Common Stock | D | 2,50 | 2,5000 | 12.677.490 | 31.694 | 14.000.000 | |||
| 2020-06-12 | 2020-06-11 | 4 | Innoviva, Inc. | ETTX | Common Stock | D | 2,5000 | 12.677.490 | 31.694 | 14.000.000 | ||||
| 2020-04-23 | 3 | Innoviva, Inc. | ETTX | Common Stock | D | 2.645.020 | ||||||||
| 2020-04-23 | 3 | Innoviva, Inc. | ETTX | Common Stock | D | 2.645.020 | ||||||||
| 2020-04-23 | 3 | Innoviva, Inc. | ETTX | Common Stock | D | 2.645.020 | ||||||||
| 2020-01-27 | 2020-01-23 | 4 | Tommasi Rubin | ETTX | Stock Option (Right to Buy) | D | 4,94 | 50.000 | 50.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | Gutch Michael | ETTX | Stock Option (Right to Buy) | D | 4,94 | 50.000 | 50.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | Keiley Elizabeth M | ETTX | Stock Option (Right to Buy) | D | 4,94 | 50.000 | 50.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | Kimble Eric Wilson | ETTX | Stock Option (Right to Buy) | D | 4,94 | 50.000 | 50.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | Perros Manoussos | ETTX | Stock Option (Right to Buy) | D | 4,94 | 145.000 | 145.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | Altarac David | ETTX | Stock Option (Right to Buy) | D | 4,94 | 50.000 | 50.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | Mueller John Patrick | ETTX | Stock Option (Right to Buy) | D | 4,94 | 50.000 | 50.000 | |||||
| 2020-01-13 | 2020-01-09 | 4 | Frazier Life Sciences VIII, L.P. | ETTX | Common Stock | D | 5,0002 | -50.000 | -250 | 1.299.953 | ||||
| 2019-11-06 | 2019-11-04 | 4 | Altarac David | ETTX | Stock Option (Right to Buy) | D | 5,70 | 120.000 | 120.000 | |||||
| 2019-08-06 | 2019-08-05 | 4 | Mayer Howard | ETTX | Stock Option (Right to Buy) | D | 6,44 | 15.000 | 15.000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | GALAKATOS NICHOLAS | ETTX | Stock Option (Right to Buy) | D | 6,12 | 7.500 | 7.500 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Preston Heather | ETTX | Stock Option (Right to Buy) | D | 6,12 | 7.500 | 7.500 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Behanna Heather | ETTX | Stock Option (Right to Buy) | D | 6,12 | 7.500 | 7.500 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Norden Gregory | ETTX | Stock Option (Right to Buy) | D | 6,12 | 7.500 | 7.500 | |||||
| 2019-06-21 | 2019-06-19 | 4 | HASTINGS DAVID C | ETTX | Stock Option (Right to Buy) | D | 6,12 | 7.500 | 7.500 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Meek David D. | ETTX | Stock Option (Right to Buy) | D | 6,12 | 15.000 | 15.000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Meek David D. | ETTX | Stock Option (Right to Buy) | D | 6,12 | 7.500 | 7.500 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Behanna Heather | ETTX | Stock Option (right to buy) | D | 5,66 | 15.000 | 15.000 | |||||
| 2019-01-22 | 2019-01-18 | 4 | GALAKATOS NICHOLAS | ETTX | Stock Option (right to buy) | D | 5,66 | 15.000 | 15.000 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Gutch Michael | ETTX | Employee Stock Option (right to buy) | D | 5,66 | 56.500 | 56.500 | |||||
| 2019-01-22 | 2019-01-18 | 4 | HASTINGS DAVID C | ETTX | Stock Option (right to buy) | D | 5,66 | 15.000 | 15.000 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Isaacs Robin | ETTX | Employee Stock Option (right to buy) | D | 5,66 | 56.500 | 56.500 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (right to buy) | D | 5,66 | 56.500 | 56.500 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Norden Gregory | ETTX | Stock Option (right to buy) | D | 5,66 | 15.000 | 15.000 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Perros Manoussos | ETTX | Employee Stock Option (right to buy) | D | 5,66 | 123.500 | 123.500 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (right to buy) | D | 5,66 | 56.500 | 56.500 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Topper James N | ETTX | Stock Option (right to buy) | D | 5,66 | 15.000 | 15.000 | |||||
| 2019-01-15 | 3 | SCHWARZMAN STEPHEN A See Footnotes | ETTX | Common Stock | I | 3.246.810 | ||||||||
| 2019-01-15 | 3 | SCHWARZMAN STEPHEN A See Footnotes | ETTX | Common Stock | I | 3.246.810 | ||||||||
| 2019-01-15 | 3 | SCHWARZMAN STEPHEN A See Footnotes | ETTX | Common Stock | I | 3.246.810 | ||||||||
| 2019-01-15 | 3 | SCHWARZMAN STEPHEN A See Footnotes | ETTX | Common Stock | I | 3.246.810 | ||||||||
| 2019-01-15 | 3 | SCHWARZMAN STEPHEN A See Footnotes | ETTX | Common Stock | I | 3.246.810 | ||||||||
| 2019-01-15 | 3 | SCHWARZMAN STEPHEN A See Footnotes | ETTX | Common Stock | I | 3.246.810 | ||||||||
| 2019-01-15 | 3 | SCHWARZMAN STEPHEN A See Footnotes | ETTX | Common Stock | I | 3.246.810 | ||||||||
| 2019-01-15 | 3 | SCHWARZMAN STEPHEN A See Footnotes | ETTX | Common Stock | I | 3.246.810 | ||||||||
| 2018-12-26 | 2018-12-21 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 3,11 | -10.236 | 24.858 | |||||
| 2018-12-26 | 2018-12-21 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 3,74 | -11.788 | 6.465 | |||||
| 2018-12-26 | 2018-12-21 | 4 | Tommasi Rubin | ETTX | Common Stock | D | 3,1100 | 10.236 | 32 | 22.024 | ||||
| 2018-12-26 | 2018-12-21 | 4 | Tommasi Rubin | ETTX | Common Stock | D | 3,7400 | 11.788 | 44 | 11.788 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Clarus Lifesciences III, L.P. | ETTX | Series B-1 Tranche B Convertible Preferred Stock | I | -8.552.024 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Clarus Lifesciences III, L.P. | ETTX | Series B-1 Tranche A Convertible Preferred Stock | I | -6.702.213 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Clarus Lifesciences III, L.P. | ETTX | Series B Convertible Preferred Stock | I | -7.500.000 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Clarus Lifesciences III, L.P. | ETTX | Common Stock | I | 15,0000 | 453.395 | 6.801 | 1.623.405 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Clarus Lifesciences III, L.P. | ETTX | Common Stock | I | 412.583 | 1.170.010 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Clarus Lifesciences III, L.P. | ETTX | Common Stock | I | 323.341 | 685.170 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Clarus Lifesciences III, L.P. | ETTX | Common Stock | I | 361.829 | 361.829 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Frazier Life Sciences VIII, L.P. | ETTX | Series B-1 Tranche B Convertible Preferred Stock | D | -6.651.574 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Frazier Life Sciences VIII, L.P. | ETTX | Series B-1 Tranche A Convertible Preferred Stock | D | -5.212.833 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Frazier Life Sciences VIII, L.P. | ETTX | Series B Convertible Preferred Stock | D | -7.000.000 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Frazier Life Sciences VIII, L.P. | ETTX | Common Stock | D | 15,0000 | 375.887 | 5.638 | 1.349.953 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Frazier Life Sciences VIII, L.P. | ETTX | Common Stock | D | 320.898 | 974.066 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Frazier Life Sciences VIII, L.P. | ETTX | Common Stock | D | 251.487 | 589.194 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Frazier Life Sciences VIII, L.P. | ETTX | Common Stock | D | 337.707 | 337.707 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | GALAKATOS NICHOLAS | ETTX | Series B-1 Tranche B Convertible Preferred Stock | I | -8.552.024 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | GALAKATOS NICHOLAS | ETTX | Series B-1 Tranche A Convertible Preferred Stock | I | -6.702.213 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | GALAKATOS NICHOLAS | ETTX | Series B Convertible Preferred Stock | I | -7.500.000 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | GALAKATOS NICHOLAS | ETTX | Common Stock | I | 15,0000 | 453.395 | 6.801 | 1.623.405 | ||||
| 2018-10-02 | 2018-09-28 | 4 | GALAKATOS NICHOLAS | ETTX | Common Stock | I | 412.583 | 1.170.010 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | GALAKATOS NICHOLAS | ETTX | Common Stock | I | 323.341 | 685.170 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | GALAKATOS NICHOLAS | ETTX | Common Stock | I | 361.829 | 361.829 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Pivotal bioVenture Partners Fund I, L.P. | ETTX | Series B-1 Tranche B Convertible Preferred Stock | I | -9.502.249 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Pivotal bioVenture Partners Fund I, L.P. | ETTX | Series B-1 Tranche A Convertible Preferred Stock | I | -7.446.904 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Pivotal bioVenture Partners Fund I, L.P. | ETTX | Common Stock | I | 15,0000 | 337.724 | 5.066 | 1.180.178 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Pivotal bioVenture Partners Fund I, L.P. | ETTX | Common Stock | I | 458.425 | 842.454 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Pivotal bioVenture Partners Fund I, L.P. | ETTX | Common Stock | I | 359.267 | 359.267 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Preston Heather | ETTX | Series B-1 Tranche B Convertible Preferred Stock | I | -9.502.249 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Preston Heather | ETTX | Series B-1 Tranche A Convertible Preferred Stock | I | -7.446.904 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Preston Heather | ETTX | Common Stock | I | 15,0000 | 337.724 | 5.066 | 1.180.178 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Preston Heather | ETTX | Common Stock | I | 458.425 | 842.454 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Preston Heather | ETTX | Common Stock | I | 359.267 | 359.267 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Sofinnova Venture Partners IX, L.P. | ETTX | Series B-1 Tranche B Convertible Preferred Stock | D | -9.502.249 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Sofinnova Venture Partners IX, L.P. | ETTX | Series B-1 Tranche A Convertible Preferred Stock | D | -7.446.904 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Sofinnova Venture Partners IX, L.P. | ETTX | Common Stock | D | 15,0000 | 337.724 | 5.066 | 1.180.178 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Sofinnova Venture Partners IX, L.P. | ETTX | Common Stock | D | 458.425 | 842.454 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Sofinnova Venture Partners IX, L.P. | ETTX | Common Stock | D | 359.267 | 359.267 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Topper James N | ETTX | Series B-1 Tranche B Convertible Preferred Stock | I | -6.651.574 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Topper James N | ETTX | Series B-1 Tranche A Convertible Preferred Stock | I | -5.212.833 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Topper James N | ETTX | Series B Convertible Preferred Stock | I | -7.000.000 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Topper James N | ETTX | Common Stock | I | 15,0000 | 375.887 | 5.638 | 1.349.953 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Topper James N | ETTX | Common Stock | I | 320.898 | 974.066 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Topper James N | ETTX | Common Stock | I | 251.487 | 589.194 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | Topper James N | ETTX | Common Stock | I | 337.707 | 337.707 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | ASTRAZENECA PLC | ETTX | Series A Preferred Stock | I | -33.499.900 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | ASTRAZENECA PLC | ETTX | Common Stock | I | 15,0000 | 246.666 | 3.700 | 2.164.855 | ||||
| 2018-10-02 | 2018-09-28 | 4 | ASTRAZENECA PLC | ETTX | Common Stock | I | 1.918.185 | 1.918.189 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses | ETTX | Series B-1 Preferred Stock | I | -15.254.237 | 0 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses | ETTX | Common Stock | I | 15,0000 | 262.539 | 3.938 | 1.020.748 | ||||
| 2018-10-02 | 2018-09-28 | 4 | TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses | ETTX | Common Stock | I | 22.285 | 758.209 | ||||||
| 2018-10-02 | 2018-09-28 | 4 | TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses | ETTX | Common Stock | I | 735.924 | 735.924 | ||||||
| 2018-10-01 | 2018-09-28 | 4 | Novo A/S | ETTX | Series B-1 Preferred Stock | D | -14.237.288 | 0 | ||||||
| 2018-10-01 | 2018-09-28 | 4 | Novo A/S | ETTX | Series B Preferred Stock | D | -7.000.000 | 0 | ||||||
| 2018-10-01 | 2018-09-28 | 4 | Novo A/S | ETTX | Common Stock | D | 15,0000 | 1.089.835 | 16.348 | 2.181.843 | ||||
| 2018-10-01 | 2018-09-28 | 4 | Novo A/S | ETTX | Common Stock | D | 1.092.008 | 1.092.008 | ||||||
| 2018-09-27 | 2018-09-25 | 4 | Gutch Michael | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | 15.956 | 15.956 | |||||
| 2018-09-27 | 2018-09-25 | 4 | Isaacs Robin | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | 32.116 | 32.116 | |||||
| 2018-09-27 | 2018-09-25 | 4 | Mueller John Patrick | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | 7.265 | 7.265 | |||||
| 2018-09-27 | 2018-09-25 | 4 | Tommasi Rubin | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | 50.411 | 50.411 | |||||
| 2018-09-27 | 2018-09-25 | 4 | Perros Manoussos | ETTX | Employee Stock Option (Right to Buy) | D | 15,00 | 79.698 | 79.698 | |||||
| 2018-09-25 | 3 | ASTRAZENECA AB | ETTX | Common Stock | I | 8 | ||||||||
| 2018-09-25 | 3 | ASTRAZENECA AB | ETTX | Common Stock | I | 8 | ||||||||
| 2018-09-25 | 3 | ASTRAZENECA AB | ETTX | Common Stock | I | 8 | ||||||||
| 2018-09-25 | 3 | ASTRAZENECA AB | ETTX | Common Stock | I | 8 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
